Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PURR-01
- Development stage
- Preclinical
- Lead developer
- The Cat Health Company
01
Overview
PURR-01 is an experimental veterinary drug candidate being developed by The Cat Health Company to treat age-related diseases in senior cats. It is part of the company's "PURR" series of longevity medicines designed to extend the healthspan of felines. The primary indications for PURR-01 include sarcopenia (muscle wasting), chronic kidney disease (CKD), and neurodegeneration. While the drug is part of a structured development pipeline that includes pre-clinical and IND-enabling stages, specific details regarding its molecular target, pharmacological modality, and exact mechanism of action have not been publicly disclosed in detail by the developer.
Beyond the preview
Go deeper on PURR-01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PURR-01.